Scott Levin, MD, joined Hempagenix™ in 2019 as vice president of clinical applications, intrigued by the idea of providing a hemp-based, over-the-counter solution for both acute and chronic pain. As the head of Hempagenix’s™ clinical division, he oversees a vast multitude of clinical applications for the company’s products, including Cannanumb™.
After graduating from the University of Pennsylvania, Dr. Levin earned his medical degree from the University of Miami Miller School of Medicine. He completed his anesthesia residency at Jackson Memorial Hospital in Miami and has been working as an anesthesiologist at Boca Raton Regional Hospital for the past 22 years. As an anesthesiologist for Sheridan Clinical Research, he has been co-investigator of several primary research clinical trials that involved analgesics.
Dr. Levin has also successfully led several small businesses, giving him a unique understanding of both the clinical and business worlds. He is certified by the American Board of Anesthesiology and is currently on the faculty at the Charles E. Schmidt College of Medicine at Florida Atlantic University.